Celcuity Inc. (NASDAQ:CELC – Get Rating) saw a large decrease in short interest in the month of October. As of October 31st, there was short interest totalling 111,200 shares, a decrease of 11.0% from the October 15th total of 125,000 shares. Based on an average daily trading volume, of 40,600 shares, the days-to-cover ratio is currently 2.7 days. Approximately 1.8% of the shares of the company are short sold.
Celcuity Trading Down 1.3 %
Celcuity stock opened at $10.00 on Wednesday. The company has a current ratio of 9.74, a quick ratio of 9.74 and a debt-to-equity ratio of 0.34. The firm has a market cap of $154.60 million, a PE ratio of -4.17 and a beta of 1.00. The stock’s 50 day simple moving average is $9.66 and its two-hundred day simple moving average is $8.87. Celcuity has a 12 month low of $4.81 and a 12 month high of $18.92.
Insider Buying and Selling
In other Celcuity news, Director Richard Nigon acquired 5,000 shares of the firm’s stock in a transaction on Friday, September 9th. The stock was acquired at an average cost of $8.99 per share, for a total transaction of $44,950.00. Following the purchase, the director now owns 96,032 shares in the company, valued at approximately $863,327.68. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In the last quarter, insiders have sold 800 shares of company stock worth $7,686. 32.90% of the stock is owned by company insiders.
Institutional Trading of Celcuity
Celcuity Inc, a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.
- Get a free copy of the StockNews.com research report on Celcuity (CELC)
- Power Integrations Stock Can Power Your Portfolio
- Don’t Chase Walmart Higher, Wait For Extra Low Prices
- Home Depot Results (and Institutions) Are A Catalyst For Lowe’s?
- Three Penny Stocks Making Big Moves In November
- Agilent Remains In Buy Range Ahead Of Next Week’s Q4 Report
Receive News & Ratings for Celcuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celcuity and related companies with MarketBeat.com's FREE daily email newsletter.